Tech Company Financing Transactions
Semma Therapeutics Funding Round
Semma Therapeutics, based in Cambridge, secured $44 million in investment from MPM Capital, Arch Venture Partners and F-Prime Capital.
Transaction Overview
Company Name
Announced On
3/25/2015
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series A
Investors
MPM Capital (Lead Investor) (Robert Millman)
F-Prime Capital (Steven Knight)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
450 Kendall St. 2B
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Not Recorded
Overview
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bastiano Sanna
Chief Financial Officer
David Cordo
Chief Marketing Officer
Moses Goddard
Chief Technical Officer
David DiGiusto
Founder
Doug Melton
Vice President
Jason Gaglia
Vice President
Christopher Thanos
VP - Operations
Jeffrey Imbaro
VP - R & D
Felicia Pagliuca
Browse more venture capital transactions:
Prev: 3/25/2015: Plum Electronics venture capital transaction
Next: 3/25/2015: Cotopaxi venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs